Status:
ENROLLING_BY_INVITATION
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertension (HTN)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level ...
Eligibility Criteria
Inclusion
- UH3 IMPLEMENTATION PHASE (Years 4 - 7): INTERVENTION
- Patients are eligible if he/she:
- identifies as Black (through EHR code or self-report)
- is 18+ years of age
- has a diagnosis of HTN (identified by ICD-10 codes for HTN)
- prescribed an antihypertensive medication(s)
- has a clinic BP \> 130/80 mmHg
Exclusion
- Patients will be ineligible for the study if they:
- are deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
- participate in other hypertension-related clinical trials
- have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
- plan to discontinue care at the site within the next 12 months; or
- are pregnant or planning to become pregnant in the next 12 months
- IMPLEMENTATION EVALUATION
- NYULH Primary care provider (MD/DO, NP), Clinical Director, Site Administrator, Medical Assistant, or administrative staff employed at the participating practices and interacts with at least five patients with a diagnosis of hypertension; or
- NYULH Nurse case manager within centralized service; or
- Staff and leadership of community- and faith-based organizations serving the Black community; or
- NYULH Organizational leadership; or
- NYULH Project Staff: Community Health Workers/CHW Supervisor/Practice Facilitators; and
- Able and willing to provide consent
Key Trial Info
Start Date :
June 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05208450
Start Date
June 12 2025
End Date
August 31 2027
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016